Tenet Healthcare Corp(THC) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | - | P/E | 10.16 | EPS (ttm) | 25.93 | Insider Own | 0.98% | Shs Outstand | 80.5M | Perf Week | 1.91% |
| Market Cap | 21.21B | Forward P/E | 12.5 | EPS next Y | -0.64% | Insider Trans | -19.19% | Shs Float | 79.7M | Perf Month | 1.55% |
| Enterprise Value | 36.33B | PEG | 1.13 | EPS next Q | 4.67 | Inst Own | 100.33% | Short Float | 3.16% | Perf Quarter | 59.9% |
| Income | 2.24B | P/S | 0.97 | EPS this Y | 26.43% | Inst Trans | -4.02% | Short Ratio | 2.21 | Perf Half Y | 12.31% |
| Sales | 21.81B | P/B | 4.55 | EPS next 5Y | 11.09% | ROA | 7.55% | Short Interest | 2.52M | Perf YTD | 32.58% |
| Book/sh | 57.86 | P/C | 9.78 | EPS past 3/5Y | 60.9% 32.77% | ROE | 53.31% | 52W High | -6.92% ($283.05) | Perf Year | 37.38% |
| Cash/sh | 26.95 | P/FCF | 7.02 | Sales past 3/5Y | 3.58% 3.85% | ROIC | 12.63% | 52W Low | 67.19% ($157.58) | Perf 3Y | 252.55% |
| Dividend Est. | - | EV/EBITDA | 8.1 | EPS Y/Y TTM | 65.86% | Gross Margin | 16.47% | Volatility(W/M) | 3.93% 3.02% | Perf 5Y | 262.34% |
| Dividend TTM | - | EV/Sales | 1.67 | Sales Y/Y TTM | 5.43% | Oper. Margin | 16.47% | ATR (14) | 8.96 | Perf 10Y | 1015.41% |
| Dividend Ex-Date | - | Quick Ratio | 1.35 | EPS Q/Q | 213.54% | Profit Margin | 10.27% | RSI (14) | 53.28 | Recom | 1.46 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.41 | Sales Q/Q | 6.77% | SMA20 | -1.72% ($268.07) | Beta | 1.19 | Target Price | $285.1 |
| Payout | - | Debt/Eq | 2.84 | Earnings | 2026/7/23 | SMA50 | 8.75% ($242.26) | Rel Volume | 0.55 | Prev Close | $269.08 |
| Employees | 99000 | LT Debt/Eq | 2.81 | EPS/Sales Surpr. | 43.63% 3.62% | SMA200 | 25.86% ($209.33) | Avg Volume(3M) | 1.14M | Price | $263.46 |
| IPO | 1971/4/28 | Option/Short | Yes/Yes | Trades | 12708 | Volume | 626,424 | Change | -2.09% |
Company
THC is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
A major US hospital and healthcare services company that operates general hospitals, outpatient surgery centers, and medical revenue management services, and provides a wide range of inpatient and outpatient care as one of America's leading healthcare facility operators.
Over the past 1 year, on the higher side
7% below its 1-year high.
THC makes money exceptionally well
16.47% of revenue is kept as operating profit.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +26.4% this year.
Tap to view numbers
The price looks about right
Trading at 10.2 times earnings.
Tap to view numbers
It has beaten expectations every time
Beat market estimates in the last 3 quarters.
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Strong Buy.
Tap to view numbers
Holding long would have paid off
Would have changed by +252.6% if bought 5 years ago.
Tap to view numbers
Dividends are hard to expect
This stock does not pay dividends
Ownership looks stable
Institutions hold 100.3%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
Special products that amplify (leveraged) or invert this single stock. They decay quickly and are not for long-term holding.
It ranks #2 in the industry
Based on market cap of $21B.
FAQ
What kind of company is THC?
THC belongs to the Healthcare sector and operates in the Medical Care Facilities industry.
What is the market cap of THC?
The market cap of THC is approximately $21.2B, ranking 590 within its sector.
What is the P/E ratio of THC?
THC has a P/E ratio of approximately 10.2x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for THC?
THC has recorded a 52-week high of $283.05 and a low of $157.58.